help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giani, C.
Right arrow Articles by Pinchera, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giani, C.
Right arrow Articles by Pinchera, A.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 990-994, Copyright © 1996 by Endocrine Society

ARTICLES

Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy

C Giani, P Fierabracci, R Bonacci, A Gigliotti, D Campani, F De Negri, D Cecchetti, E Martino and A Pinchera
Institute of Endocrinology, University of Pisa, Italy.

The relationship between thyroid dysfunction and breast cancer (BC) is debated. To clarify this controversial issue, a prospective study on thyroid function in BC was performed. The prevalence of thyroid disease was examined in 102 consecutive BC patients with ductal infiltrating carcinoma after surgery and before starting any chemohormonal or x-ray therapy and in 100 age-matched control healthy women living in the same borderline iodine-sufficient geographic area. All subjects were submitted to clinical ultrasound thyroid evaluation and serum free T4, free T3, TSH, thyroperoxidase antibody, and thyroglobulin antibody determination. Fine needle aspiration was performed in all thyroid nodules. Estrogen and progesterone receptors (ER and PR, respectively) were assayed in 92 and 55 BC specimens, respectively. The overall prevalence of thyroid disease was 47 in 102 (46%) in BC patients and 14 in 100 (14%) in controls (P < 0.0001). The prevalence of nontoxic goiter was 27.4% in BC patients and 11% in controls (P = 0.003). Hashimoto's thyroiditis was found in 13.7% of BC patients and in only 2% of the controls (P < 0.005). Other thyroid disorders found in the BC group included 2 cases of Graves' disease, 2 of thyroid carcinoma, and 1 of subacute thyroiditis, whereas in the control group only 1 case of Graves' disease and none of the other disorders were found. Mean free T3, free T4, and TSH concentrations showed no difference between BC patients and controls. The prevalence of thyroperoxidase antibody was higher in BC patients than in controls (23.5% vs. 8%; P < 0.005), whereas the prevalence of thyroglobulin antibody was not different. In BC patients the presence of thyroid antibodies was more frequently associated with clinically detectable autoimmune thyroiditis (14 of 26, 51.8%; P = 0.03) and was more common in the younger group. The positivity of ER was found in 51 of 92 (55.43%) and that of PR was found in 26 of 55 (47.27%) BC specimens. No relationship was found among ER, PR status, and the presence of serum thyroid antibodies. In conclusion, 1) the present study provides evidence that the overall prevalence of thyroid disorders is increased in patients with breast cancer, and 2) thyroid autoimmune disorders, especially Hashimoto's thyroiditis, account to a large extent for the increased prevalence of thyroid disease in patients with breast cancer. This feature is independent from the ER and PR status of the primary tumor. The present findings call attention to the usefulness of screening for thyroid disease in any patient with breast cancer.


This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
E Giustarini, A Pinchera, P Fierabracci, M Roncella, L Fustaino, C Mammoli, and C Giani
Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery.
Eur. J. Endocrinol., May 1, 2006; 154(5): 645 - 649.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. T. Kilbane, R. A. Ajjan, A. P. Weetman, R. Dwyer, E. W. M. McDermott, N. J. O’Higgins, and P. P. A. Smyth
Tissue Iodine Content and Serum-Mediated 125I Uptake-Blocking Activity in Breast Cancer
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1245 - 1250.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. P. A. Smyth, S. G. Shering, M. T. Kilbane, M. J. Murray, E. W. M. McDermott, D. F. Smith, and N. J. O’Higgins
Serum Thyroid Peroxidase Autoantibodies, Thyroid Volume, and Outcome in Breast Carcinoma
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2711 - 2716.
[Abstract] [Full Text]

Home page
 BMJHome page
A P Weetman
Fortnightly review: Hypothyroidism: screening and subclinical disease
BMJ, April 19, 1997; 314(7088): 1175 - 1175.
[Full Text]

Home page
 JWatch Women's HealthHome page
Are Thyroid Disorders More Common in Breast Cancer Patients?
Journal Watch Women's Health, April 1, 1996; 1996(401): 23 - 23.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society